Table 1. Demographic- and Immunotherapy-Related Characteristics of Patients in This Study.
| Variables | n=267 (%) |
|---|---|
| Age (yr) | 25.6±15.4 (1–69) |
| 1–9 | 35 |
| 10–19 | 82 |
| 20–29 | 45 |
| 30–39 | 51 |
| 40–49 | 30 |
| 50–59 | 20 |
| 60–69 | 3 |
| Sex, male | 133 (49.8) |
| Family history of allergic diseases | 211 (79.0) |
| Indicated diseases for AIT (duplicated) | |
| Asthma | 114 (42.7) |
| Allergic rhinoconjunctivitis | 244 (91.4) |
| Atopic dermatitis | 54 (20.2) |
| Previous AIT history | 27 (10.2) |
| Mean duration of AIT (month) | 27.3±15.0 (12–90) |
| Information source of AIT | |
| General hospital physician | 165 (69.6) |
| General practitioner | 14 (5.9) |
| Acquaintances | 33 (13.9) |
| Internet/media | 19 (8.0) |
| Other patients | 1 (0.4) |
| Others | 5 (2.1) |
| Subjective adherence to AIT (patients) | |
| Excellent | 239 (91.6) |
| Good | 7 (2.7) |
| Pair | 8 (3.1) |
| Poor | 4 (1.5) |
| Very poor | 3 (1.1) |
AIT, allergen-specific immunotherapy.
Family history represents to have allergic diseases in the direct blood relatives of the patient. Data are presented as a mean±SD (range) or number (percentage).